Antimetabolites: all 7,479 studies that test it
Page 60 of 75. Open to participants first (1,134), then studies with results posted, then the rest; newest registration first within each.
- Phase 2 Study of Azacitidine (Vidaza) vs MGCD0103 vs Combination in Elderly Subjects With Newly Diagnosed Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS)TerminatedNCT00666497Phase 2
- Dose Response and Safety Study of Topical Methotrexate for the Treatment of Fingernail PsoriasisStatus unknownNCT00666354Phase 2
- A Phase I Trial of Normothermic Isolated Limb Infusion (ILI) With Melphalan Plus Buthionine Sulfoximine (BSO) in Patients With Locally Advanced Malignant MelanomaWithdrawnNCT00661336Phase 1
- Tegafur-Uracil and Leucovorin or S-1 in Treating Patients With Stage III Colon Cancer That Has Been Completely Removed by SurgeryCompletedNCT00660894Phase 3
- Study of GemOx and Vandetanib in Advanced Solid MalignancyCompletedNCT00660725Phase 1
- Study Of Advanced Gastrointestinal Malignancies And Other Solid TumorsCompletedNCT00660426Phase 1
- Chemotherapy and Radiation Following Pancreatic SurgeryCompletedNCT00660270Phase 2
- Gemcitabine and Bexarotene in Treating Patients With Progressive or Refractory Stage IB, Stage II, Stage III, or Stage IV Cutaneous T-cell Non-Hodgkin LymphomaCompletedNCT00660231Phase 2
- Study of Gemcitabine and Carboplatin in the Treatment of Metastatic or Recurrent Cholangiocarcinoma/Gallbladder CancerCompletedNCT00660140Phase 2
- Neo-adjuvant Therapy and the Effect on Synchronous Metastatic GrowthStatus unknownNCT00659022Phase 2
- Concurrent Chemo-radiotherapy With Capecitabine for Unresectable Locally Advanced Pancreatic CarcinomaStatus unknownNCT00658840Phase 2
- Gemcitabine With/Out Capecitabine in Locally Advanced, Unresectable, or Metastatic Biliary CancerTerminatedNCT00658593Phase 3
- APRiCOT-B: Study to Evaluate Apricoxib in Combination With Lapatinib and Capecitabine in the Treatment of HER2/Neu+ Breast Cancer (TP2001-202)TerminatedNCT00657137Phase 2
- Rituximab Plus 2CdA in Patients With Advanced or Relapsed Mucosa Associated Lymphoid Tissue (MALT) LymphomaCompletedNCT00656812Phase 2
- Trial to Define the Safety and Tolerability of SGN-40, Rituximab, and Gemcitabine in Patients With DLBCLCompletedNCT00655837Phase 1
- Antiangiogenic Peptide Vaccine Therapy With Gemcitabine in Treating Patient With Pancreatic Cancer (Phase1/2)CompletedNCT00655785Phase 1/2
- Irinotecan, Fluorouracil, and Leucovorin in Treating Patients With Advanced Gastrointestinal CancerCompletedNCT00654160Phase 1
- Bioavailability Study of Leflunomide Tablets Under Fed ConditionsCompletedNCT00653003Phase 1
- Bioavailability Study of Leflunomide Tablets Under Fasting ConditionsCompletedNCT00652665Phase 1
- Phase 2 Study of S-1 as 2nd Line Therapy in Advanced Non-Small Cell Lung CancerCompletedNCT00652561Phase 2
- Phase 2 Study of S-1 as 2nd Line Therapy in Metastatic Pancreatic CancerCompletedNCT00652054Phase 2
- Phase 2 Study of S-1 in Combination With Cisplatin as 1st Line Therapy in Advanced Non-Small Cell Lung CancerCompletedNCT00651833Phase 2
- A Phase I Dose Escalation Study of SGN-35 Alone and in Combination With Gemcitabine for CD30-Positive MalignanciesTerminatedNCT00649584Phase 1
- Fasting Study of Mercaptopurine 50 mg and Purinethol® Tablets 50 mgCompletedNCT00648336Phase 1
- Association Corticosteroid/Azathioprine in Microscopic Polyangiitis/ Polyarteritis Nodosa or Eosinophilic Granulomatosis With Polyangiitis (Churg Strauss Syndrome)CompletedNCT00647166Phase 3
- Freiburg ZNS-NHL StudyStatus unknownNCT00647049Phase 2
- Epirubicin, Docetaxel, and Capecitabine in Treating Women With Stage IIIA or Stage IIIB Breast CancerCompletedNCT00645866Phase 2
- Comparison of Subconjunctival 5-Fluorouracil (FU) Injection and Mitomycin C for Treatment of Early Bleb FailureStatus unknownNCT00644215Not applicable
- A Study of First Line Treatment With Tarceva (Erlotinib) in Combination With Gemcitabine in Patients With Locally Advanced Unresectable or Metastatic Pancreatic CancerTerminatedNCT00642733Phase 4
- Clofarabine and High-Dose Melphalan Followed by Donor Stem Cell Transplant in Patients With Acute Myeloid Leukemia, Acute Lymphocytic Leukemia, or Myelodysplastic SyndromesCompletedNCT00641030Phase 1
- The Effect of Allopurinol on Insulin Resistance and Blood PressureCompletedNCT00639756Phase 2
- Dose Escalation Study of Liposomal Paclitaxel With/Without Capecitabine in Patients With Advanced Gastric CarcinomaStatus unknownNCT00639522Phase 1
- Second Line Chemotherapy for S-1 Refractory Advanced Gastric CancerCompletedNCT00639327Phase 2/3
- Leflunomide in Systemic Lupus ErythematosusCompletedNCT00637819Phase 2
- Nonmyeloablative Allo SCT for the Treatment of Hematologic DisordersCompletedNCT00636909Phase 2
- Oxaliplatin, Gemcitabine, and Erlotinib Study in Patients With Advanced Chemo-naïve Pancreatic CancerTerminatedNCT00636883Phase 2
- Methotrexate, Vinblastine, Doxorubicin and Cisplatin (MVAC) Followed by Gemcitabine Plus Cisplatin (GEM+CDDP) in Locally Advanced or Metastatic Bladder CancerTerminatedNCT00635726Phase 2
- Safety And Efficacy Of Irinotecan Plus Capecitabine As First-Line Treatment In Asian Subjects With Hepatocellular CarcinomaCompletedNCT00635323Phase 2
- Gemcitabine With or Without Capecitabine and/or Radiation Therapy or Gemcitabine With or Without Erlotinib in Treating Patients With Locally Advanced Pancreatic Cancer That Cannot Be Removed by SurgeryCompletedNCT00634725Phase 3
- Low-dose RAD001(Everolimus) Plus Cisplatin-HDFL Chemotherapy for the First-line Treatment of Advanced Gastric CancerCompletedNCT00632268Phase 2
- Study of Alimta in Patients With Recurrent or Metastatic Nasopharyngeal Carcinoma (NPC) Who Have Had Prior Platinum Based ChemotherapyCompletedNCT00630149Phase 2
- Phase 3 Study of Surgery Combined With Neoadjuvant Chemotherapy(XELOX) in Colorectal Cancer With Resectable Liver MetastasisStatus unknownNCT00630045Phase 3
- Sequential Versus Simultaneous Use of Vinorelbine and Capecitabine in Patients With Metastatic Breast Cancer (MBC)CompletedNCT00629148Phase 2
- Donor Stem Cell Transplant After Busulfan, Fludarabine, and Antithymocyte Globulin in Treating Patients With Hematological CancerCompletedNCT00627666Phase 2
- Azathioprine Versus Placebo in Pemphigus Vulgaris Treated With PrednisoloneCompletedNCT00626678Phase 2
- Gemcitabine and Capecitabine to Treat Patients With Advanced Pancreatic and Biliary CancersCompletedNCT00626158Phase 1
- A Phase I Gene Therapy Study of FP253/Fludarabine for Prostate CancerStatus unknownNCT00625430Phase 1
- Study of Developing an Optimal Gemcitabine Based Regimen to Treat Elderly Patients With Advanced Non-Small Cell CarcinomaStatus unknownNCT00625352Phase 2
- Azacytidine and Bortezomib in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic SyndromesCompletedNCT00624936Phase 1
- Gemcitabine With Peptide Vaccine Therapy in Treating Patients With Bile Duct CancerSuspendedNCT00624182Phase 1
- Lapatinib, Cisplatin, Gemcitabine as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Urothelial CancerCompletedNCT00623064Phase 1
- Gemcitabine With Antiangiogenic Peptide Vaccine Therapy in Patients With Pancreatic CancerCompletedNCT00622622Phase 1
- Randomised Study Comparing Three Chemotherapy Regimens in Non-small Cell Lung CancerCompletedNCT00622349Phase 3
- Vaccine Therapy and GM-CSF in Treating Patients With CNS LymphomaWithdrawnNCT00621036Phase 2
- Cisplatin/Vinorelbine/Bevacizumab Followed by Docetaxel/Gemcitabine/Bevacizumab Versus the Cisplatin/Docetaxel/Bevacizumab Combination in Locally Advanced or Metastatic NSCLCCompletedNCT00620971Phase 2
- Bortezomib and Gemcitabine in Treating Older Patients With Advanced Solid TumorsCompletedNCT00620295Phase 1
- A Phase I Study Of Pazopanib With Either Erlotinib Or Pemetrexed In Patients With Advanced Solid TumorsCompletedNCT00619424Phase 1
- Bronchial Artery Infusion of Gemcitabine in Treating Patients With Recurrent or Progressive Non-Small Cell Lung CancerTerminatedNCT00619021Phase 1
- A Study To Find The Best Doses Of SU011248 (Sunitinib) And Capecitabine When These Drugs Are Administered TogetherCompletedNCT00618124Phase 1
- A Study To Find The Best Doses Of SU011248 And Gemcitabine When Given Together To Patients With Advanced Solid TumorsCompletedNCT00615446Phase 1
- Irinotecan Plus Cisplatin vs Pemetrexed Plus Cisplatin as 2nd Line in NSCLC Stage IIIB/IVCompletedNCT00614965Phase 2
- Adjuvant Docetaxel Plus Gemcitabine in Patients With Completely Resected Leiomyosarcoma (LMS) of the UterusCompletedNCT00614835Not applicable
- Bevacizumab, Erlotinib and Capecitabine for Advanced Pancreatic CancerCompletedNCT00614653Phase 1
- Combination Chemotherapy Based on Risk of Relapse in Treating Young Patients With Acute Lymphoblastic LeukemiaCompletedNCT00613457Phase 3
- Study of the Pharmacokinetics/Safety of Sorafenib + Capecitabine in Advanced Solid TumorsCompletedNCT00613145Phase 1
- Ph I Zactima + Imatinib Mesylate & Hydroxyurea for Pts w Recurrent Malignant GliomaCompletedNCT00613054Phase 1
- Obatoclax, Fludarabine, and Rituximab in Treating Patients With Previously Treated Chronic Lymphocytic LeukemiaTerminatedNCT00612612Phase 1
- Endometrial Cancer - LOHP Alone and With 5FUCompletedNCT00612495Phase 2
- Sirolimus, Tacrolimus and Short Course Methotrexate for Prevention of Acute GVHD in Recipients of Mismatched Unrelated Donor Allogeneic Stem Cell TransplantationCompletedNCT00612274Early Phase 1
- Phase II Study of Oxaliplatin in Combination With 5-Fu in 1st Line Treatment of Locally Advanced or Metastatic Squamous Cell Carcinoma of the Head and NeckCompletedNCT00611754Phase 2
- A Phase II Study of Oxaliplatin in Association With 5FU and Folinic Acid in the Treatment of Subjects With Non-Surgical or Advanced Metastatic Gastric CancerCompletedNCT00611507Phase 2
- Everolimus, Fluorouracil, Leucovorin, Panitumumab, and Oxaliplatin in Treating Patients With Tumors That Did Not Respond to TreatmentCompletedNCT00610948Phase 1
- Chlorambucil or Fludarabine as First-Line Therapy in Treating Patients With Previously Untreated Waldenström Macroglobulinemia, Splenic Lymphoma, or Lymphoplasmacytic LymphomaCompletedNCT00608374Phase 3
- 5FU vs 5FU With Viscoelastic Formulation for the Prevention of Scarring Post-trabeculectomyCompletedNCT00607685Phase 4
- Study of Capecitabine in Combination With SIR-Spheres in Patients With Advanced CancerCompletedNCT00604409Phase 1
- S-1 Versus 5-FU Bolus in Metastatic Pancreatic Cancer Patients Previously Treated With Gemcitabine-Based RegimenTerminatedNCT00602745Phase 3
- Bevacizumab, Combination Chemotherapy, and Radiation Therapy in Treating Patients Undergoing Surgery For Locally Advanced Pancreatic CancerCompletedNCT00602602Phase 2
- Bioequivalence Study of 6-Mercaptopurine Under Fasting ConditionsCompletedNCT00602134Not applicable
- Capecitabine and Streptozocin With or Without Cisplatin in Treating Patients With Unresectable or Metastatic Neuroendocrine TumorsCompletedNCT00602082Phase 2
- Imatinib, Capecitabine, and Cisplatin in Treating Patients With Unresectable or Metastatic Stomach CancerCompletedNCT00601510Phase 1
- Gemcitabine and Cisplatin as First Line Combination Therapy in Patients With Triple-negative MBCCompletedNCT00601159Phase 2
- A Phase I/Expansion Study of DasatinibTerminatedNCT00598091Phase 1
- Leflunomide EfficAcy Response Related to Dosing Regimen in Early Rheumatoid ArthritisCompletedNCT00596206Phase 3
- Drug Discrimination in Methadone-Maintained Humans Study 1CompletedNCT00593463Phase 1
- Temsirolimus in Combination With Gemcitabine in Previously Untreated Metastatic Pancreatic CancerTerminatedNCT00593008Phase 1
- A Randomized Trial Assessing the Roles of AraC in Newly Diagnosed APL Promyelocytic Leukemia (APL)CompletedNCT00591526Phase 3
- Capecitabine and Interferon-Alpha in Metastatic Renal Cell Carcinoma Patients With Failure on Interleukin-2 Based RegimensCompletedNCT00591188Phase 2
- A Phase-II Study Of TOMUDEX Plus Radiotherapy In Subject With Inoperable or Recurrent Rectal CancerCompletedNCT00590278Phase 2
- An All-Oral Combination of Capecitabine and Cyclophosphamide in Patients With Metastatic Breast Cancer (MBC)Status unknownNCT00589901Phase 2
- Sequential Administration of Oral 6-Thioguanine (6-TG) After Methotrexate (MTX) in Patients With Relapsed Hodgkin's Disease (Phase II)CompletedNCT00587873Phase 2
- Phase II Study of Perioperative S-1 Plus Docetaxel in Patients With Localized Advanced Gastric CancerStatus unknownNCT00587145Phase 2
- S-1 vs Capecitabine in the Elderly and/or Poor Performance Status Patients With Recurrent or Metastatic Gastric CancerStatus unknownNCT00580359Phase 2
- Treatment of Early RA: Minocycline in Combination With Methotrexate vs Methotrexate AloneCompletedNCT00579644Phase 3
- Clofarabine and Gemtuzumab in Treating Patients With Relapsed or Refractory Acute Myeloid LeukemiaTerminatedNCT00577694Phase 1
- Fludarabine, Pixantrone and Rituximab vs Fludarabine and Rituximab forRelapsed or Refractory Indolent NHLWithdrawnNCT00577161Phase 3
- A Study of MabThera (Rituximab) in Patients With Rheumatoid Arthritis Who Have Had an Inadequate Response to a Single Anti-TNF Inhibitor.CompletedNCT00576433Phase 4
- Pilot Trial of Arsenic + Cytarabine in Patients With MyelofibrosisCompletedNCT00572065Early Phase 1
- Phase II Trial of Combination Therapy With Irinotecan, S-1, and Bevacizumab (IRIS/Bev) in Patients With Unresectable or Recurrent Colorectal CancerCompletedNCT00569790Phase 2
- Phase II Trial of Combination Therapy With Bevacizumab and S-1 in Elderly Patients With Unresectable or Recurrent Colorectal Cancer (BASIC)CompletedNCT00569699Phase 2
- Phase II Trial of Combination Therapy With S-1, Irinotecan, and Bevacizumab (SIRB) in Patients With Unresectable or Recurrent Colorectal CancerCompletedNCT00569335Phase 2